Our CEO Prof Lindy Durrant will be speaking at the World Vaccine Congress in Barcelona on Thursday 19th October at 11am about Scancell’s cancer vaccines SCIB1 and Modi-1.
#WVCEU#Cancervaccines#Immunooncology#Immunotherapy
Scancell is pleased to announce the Safety Review Committee has given the go-ahead for expanding the checkpoint inhibitor combination expansion cohorts in its ModiFY trial.
https://t.co/qF8yrbPL0E
Dr Robert Miller, Scancell’s Medical Director, will be presenting our poster on Modi-1 at #ASCO23. Find us at: https://t.co/UsfgT1Ea70
https://t.co/feN8tGlUIv
On International Clinical Trials Day 2023, we would like to recognise all the patients who have participated in our clinical trials of novel immunotherapies for cancer.
https://t.co/tCzdx60dkU
https://t.co/mSV7LHGuvf
Today, 29th April 2023, is World Immunology Day. To commemorate this day, we are sharing our latest article that highlights our ground-breaking approach to developing innovative #cancer#vaccines.
Follow the link to read the paper: https://t.co/2jvYwcGnlw
#Moditope
PharmaJet announces clinical results from Scancell’s COVID-19 DNA vaccine study exclusively administered with their needle-free precision delivery systems.
To learn more follow the link below:
https://t.co/H1FbT0etF3
$SCLP Scancell announces appointment of Dr Jean-Michel Cosséry as its non-executive chairman with immediate effect https://t.co/VbUksjBzDL @scancellpharma $SCNLF #SCLP#SCNLF